Functional endothelial cells derived from embryonic stem cells labeled with HIV transactivator peptide-conjugated superparamagnetic nanoparticles

Chinese Medical Journal

Volumn 124, Issue 2, 2011, Pages 298-303

  Gao, Bin ^a   Fu, Wei Guo ^a   Dong, Zhi Hui ^a   Fang, Zheng Dong ^a   Liu, Zhen Jie ^b   Si, Yi ^a   Zhang, Xiang Man ^a   Wang, Yu Qi ^a  

^a FUDAN UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Cell differentiation; Embryonic stem cells; Endothelial cells; Ferumoxides

Indexed keywords

LOW DENSITY LIPOPROTEIN; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; TRANSACTIVATOR PROTEIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL LABELING; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; CELL SURVIVAL; EMBRYONIC STEM CELLS; ENDOTHELIAL CELLS; FERRIC COMPOUNDS; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79551716668     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.02.027     Document Type: Article

References (24)

1. Rosenthal N. Prometheus's vulture and the stem-cell promise. N Engl J Med 2003; 349: 267-274.
2. Borysiewicz L. Banking on the future of stem cells. Leszek Borysiewicz, head of the UK Medical Research Council (MRC), interviewed by Monya Baker. Nature 2008; 452: 263.
3. Nishikawa S, Jakt LM, Era T. Embryonic stem-cell culture as a tool for developmental cell biology. Nat Rev Mol Cell Biol 2007; 8: 502-507.
4. Nishikawa SI, Nishikawa S, Hirashima M, Matsuyoshi N, Kodama H. Progressive lineage analysis by cell sorting and culture identifies FLK1+VE-cadherin+ cells at a diverging point of endothelial and hemopoietic lineages. Development 1998; 125: 1747-1757.
5. Hirashima M, Kataoka H, Nishikawa S, Matsuyoshi N. Maturation of embryonic stem cells into endothelial cells in an in vitro model of vasculogenesis. Blood 1999; 93: 1253-1263.
6. McCloskey KE, Lyons I, Rao RR, Stice SL, Nerem RM. Purified and proliferating endothelial cells derived and expanded in vitro from embryonic stem cells. Endothelium 2003; 10: 329-336.
7. Levenberg S, Golub JS, Amit M, Itskovitz-Eldor J, Langer R. Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A 2002; 99: 4391-4396.
8. Kaufman DS, Lewis RL, Hanson ET, Auerbach R, Plendl J, Thomson JA. Functional endothelial cells derived from rhesus monkey embryonic stem cells. Blood. 2004; 103: 1325-1332.
9. Cho SW, Moon SH, Lee SH, Kang SW, Kim J, Lim JM, et al. Improvement of postnatal neovascularization by human embryonic stem cell derived endothelial-like cell transplantation in a mouse model of hindlimb ischemia. Circulation 2007; 116: 2409-2419.
10. Li Z, Wu JC, Sheikh AY, Kraft D, Cao F, Xie X, et al. Differentiation, survival, and function of embryonic stem cell derived endothelial cells for ischemic heart disease. Circulation 2007; 116: I46-I54.
11. Li Z, Han Z, Wu JC. Transplantation of human embryonic stem cell-derived endothelial cells for vascular diseases. J Cell Biochem 2009; 106: 194-199.
12. Hoehn M, Wiedermann D, Justicia C, Ramos-Cabrer P, Kruttwig K, Farr T, et al. Cell tracking using magnetic resonance imaging. J Physiol 2007; 584: 25-30.
13. Yeh TC, Zhang W, Ildstad ST, Ho C. Intracellular labeling of T-cells with superparamagnetic contrast agents. Magn Reson Med 1993; 30: 617-625.
14. Yeh TC, Zhang W, Ildstad ST, Ho C. In vivo dynamic MRI tracking of rat T-cells labeled with superparamagnetic iron-oxide particles. Magn Reson Med 1995; 33: 200-208.
15. Schoepf U, Marecos EM, Melder RJ, Jain RK, Weissleder R. Intracellular magnetic labeling of lymphocytes for in vivo trafficking studies. Biotechniques 1998; 24: 642-646, 648-651.
16. Fawell S, Seery J, Daikh Y, Moore C, Chen LL, Pepinsky B, et al. Tat-mediated delivery of heterologous proteins into cells. Proc Natl Acad Sci U S A 1994; 91: 664-668.
17. Brooks H, Lebleu B, Vives E. Tat peptide-mediated cellular delivery: back to basics. Adv Drug Deliv Rev 2005; 57: 559-577.
18. Josephson L, Tung CH, Moore A, Weissleder R. High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjug Chem 1999; 10: 186-191.
19. Lewin M, Carlesso N, Tung CH, Tang XW, Cory D, Scadden DT, et al. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol 2000; 18: 410-414.
20. Dodd CH, Hsu HC, Chu WJ, Yang P, Zhang HG, Mountz JD Jr, et al. Normal T-cell response and in vivo magnetic resonance imaging of T cells loaded with HIV transactivator- peptide-derived superparamagnetic nanoparticles. J Immunol Methods 2001; 256: 89-105.
21. Farrell E, Wielopolski P, Pavljasevic P, van Tiel S, Jahr H, Verhaar J, et al. Effects of iron oxide incorporation for long term cell tracking on MSC differentiation in vitro and in vivo. Biochem Biophys Res Commun 2008; 369: 1076-1081.
22. Kostura L, Kraitchman DL, Mackay AM, Pittenger MF, Bulte JW. Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis. NMR Biomed 2004; 17: 513-517.
23. Jia H, Lohr M, Jezequel S, Davis D, Shaikh S, Selwood D, et al. Cysteine-rich and basic domain HIV-1 Tat peptides inhibit angiogenesis and induce endothelial cell apoptosis. Biochem Biophys Res Commun 2001; 283: 469-479.
24. Vittet D, Prandini MH, Berthier R, Schweitzer A, Martin-Sisteron H, Uzan G, et al. Embryonic stem cells differentiate in vitro to endothelial cells through successive maturation steps. Blood 1996; 88: 3424-3431.